COMPASS Pathways (CMPS)
NASDAQ: CMPS
· Real-Time Price · USD
4.78
0.07 (1.49%)
At close: Sep 04, 2025, 11:11 AM
1.49% (1D)
| Bid | 3.53 |
| Market Cap | 447.34M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -138.56M |
| EPS (ttm) | -1.81 |
| PE Ratio (ttm) | -2.64 |
| Forward PE | -2.97 |
| Analyst | Buy |
| Ask | 4.8 |
| Volume | 915,390 |
| Avg. Volume (20D) | 2,933,790 |
| Open | 4.71 |
| Previous Close | 4.71 |
| Day's Range | 4.68 - 4.97 |
| 52-Week Range | 2.25 - 7.53 |
| Beta | 2.17 |
About CMPS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-0.65%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
1 month ago
+3.72%
Shares of psychedelic companies are trading higher following a report suggesting California Governor Newsom said he is "all in" on expanding access to psychedelics for therapeutic use.
20 minutes ago · seekingalpha.com
COMPASS Pathways Plc (CMPS) Presents At Cantor Global Healthcare Conference 2025 TranscriptCOMPASS Pathways plc (NASDAQ:CMPS ) Cantor Global Healthcare Conference 2025 September 3, 2025 1:35 PM EDT Company Participants Kabir Nath - CEO & Director Guy Goodwin - Chief Medical Officer Steve Le...
1 month ago · fool.com
Compass (CMPS) Q2 Loss Improves 27%Compass (CMPS) Q2 Loss Improves 27%
